Update on Management of Squamous Cell Esophageal Cancer.
Waters JK, Reznik SI.
Curr Oncol Rep. 2022 Mar;24(3):375-385. doi: 10.1007/s11912-021-01153-4. Epub 2022 Feb 10.
Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise.
Lander S, Lander E, Gibson MK.
Curr Gastroenterol Rep. 2023 Nov;25(11):275-279. doi: 10.1007/s11894-023-00899-0. Epub 2023 Oct 9.
Esophageal cancer: emerging therapeutics.
Rogers JE, Sewastjanow-Silva M, Waters RE, Ajani JA.
Expert Opin Ther Targets. 2022 Feb;26(2):107-117. doi: 10.1080/14728222.2022.2036718. Epub 2022 Feb 12.
Research Progress of Multiple Primary Malignancies Associated With Esophageal Cancer.
Cui Y, Ren W, Du X, Yang L, Tan B.
Cancer Control. 2023 Jan-Dec;30:10732748231176641. doi: 10.1177/10732748231176641.
Primary Chemoradiotherapy for Older Patients With Esophageal Cancer.
Eads JR, Haller DG.
JAMA Oncol. 2021 Oct 1;7(10):1451-1452. doi: 10.1001/jamaoncol.2021.2668.
Esophageal Cancer: Role of Imaging in Primary Staging and Response Assessment Post Neoadjuvant Therapy.
Griffin Y.
Semin Ultrasound CT MR. 2016 Aug;37(4):339-51. doi: 10.1053/j.sult.2016.02.003. Epub 2016 Feb 16.
Esophageal Cancer in Tanzania: A Welcome Stimulus in Primary Prevention Research.
McCormack V, Kaimila B, Mmbaga BT, Schüz J.
Cancer Epidemiol Biomarkers Prev. 2021 Feb;30(2):248-251. doi: 10.1158/1055-9965.EPI-20-1518.
Secondary primary lung cancer after esophageal cancer: a population-based study of 44,172 patients.
Gao Y, Qiu J, Gu L, Yang Y, Kang H, Zhang Y, Zhang S, Zhang Y, Wang H, Zhang Y, Qian J.
Scand J Gastroenterol. 2022 Feb;57(2):222-231. doi: 10.1080/00365521.2021.1994639. Epub 2021 Nov 2.
Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.
Nandy N, Dasanu CA.
Curr Med Res Opin. 2013 Sep;29(9):1055-65. doi: 10.1185/03007995.2013.816276. Epub 2013 Jul 9.
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).
Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group.
Jpn J Clin Oncol. 2013 Jul;43(7):752-5. doi: 10.1093/jjco/hyt061. Epub 2013 Apr 26.
